References
- Aboulghar M. A., Mansour R. T. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Human Reproduction Update 2003; 9: 275–289
- Abramov Y., Elchalal U., Schenker J. G. An ‘epidemic’ of severe OHSS: a price we have to pay?. Human Reproduction 1999; 14: 2181–2183
- Al-Shawaf T., Grudzinskas J. G. Prevention and treatment of ovarian hyperstimulation syndrome. Best Practice and Research in Clinical Obstetrics and Gynaecology 2003; 17: 249–261
- American Society for Reproductive Medicine Practice Committee. Ovarian hyperstimulation syndrome. Fertility and Sterility 2004; 82: S81–S86
- Amit A., Yaron Y., Yovel I., Peyser M. R., David M. P., Botchan A., Lessing J. B. Repeated aspiration of ovarian follicles and early corpus luteum cysts in an in-vitro fertilization programme reduces the risk of ovarian hyperstimulation syndrome in high responders. Human Reproduction 1993; 8: 1184–1186
- Amso N. N., Ahuja K. K., Morris N., Shaw R. W. The management of predicted ovarian hyperstimulation involving gonadotrophin-releasing hormone analogue with elective cryopreservation of all pre-embryos. Fertility and Sterility 1990; 53: 1087–1090
- Asch R. H., Li H. P., Balmaceda J. P., Weckstein L. N., Stone S. C. Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. Human Reproduction 1991; 6: 1395–1399
- Beerendonk C., van Dop P. A., Braat D. D. M., Merkus J. M. W. M. Ovarian hyperstimulation syndrome: facts and fallacies. Obstetrical and Gynecological Survey 1998; 53: 439–449
- Blankstein J., Shalev J., Saadon T., Kukia E. E., Rabinovici J., Pariente C., et al. Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles. Fertility and Sterility 1987; 47: 597–602
- Caligara C., Navarro J., Vargas G., Simon C., Pellicer A., Remohi J. The effect of repeated controlled ovarian stimulation in donors. Human Reproduction 2001; 16: 2320–2323
- Delvigne A., Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Human Reproduction Update 2002; 8: 559–577
- Delvigne A., Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Human Reproduction Update 2003; 9: 77–96
- Enskog A., Henriksson M., Unander M., Nilsson L., Brännström M. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilisation. Fertility and Sterility 1999; 71: 808–814
- Evbuomwan I. O., Davison J. M., Murdoch A. P. Coexistent hemoconcentration and hypoosmolality during superovulation and in severe ovarian hyperstimulation syndrome: a volume homeostasis paradox. Fertility and Sterility 2000; 74: 67–72
- Forman R. G., Frydman R., Egan D., Ross C., Barlow D. H. Severe hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention. Fertility and Sterility 1990; 53: 502–509
- Gamzu R., Almog B., Levin Y., Avni A., Lessing J. B., Baram A. Efficacy of hydroxyethyl starch and haemaccel for the treatment of severe ovarian hyperstimulation syndrome. Fertility and Sterility 2002; 77: 1302–1303
- MacDougall M. J., Tan S. L., Balen A. H., Jacobs H. S. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Human Reproduction 1993; 8: 233–237
- Murdoch A. P., Evbuomwan I. Severe complications of ovarian hyperstimulation syndrome are preventable. Human Reproduction 1999; 14: 2922–2924
- Navot D., Relou A., Birkenfeld A., Rabinowitz R., Brzezinski A., Margalioth E. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. American Journal of Obstetrics and Gynecology 1988; 159: 210–215
- Rizk B. Ovarian hyperstimulation syndrome. Progress in obstetrics and gynaecology, J. W. W. Studd. Churchill Livingstone, London 1995; 11: 311–349
- Sauer M. V. Defining the incidence of serious complications experienced by oocyte donors: a review of 1000 cases. American Journal of Obstetrics and Gynecology 2001; 184: 277–278
- Sher G., Zouves C., Feinman M., Maassarani G. Prolonged coasting: an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Human Reproduction 1995; 10: 3107–3109
- Stewart J. A., Hamilton P. J., Murdoch A. P. Thromboembolic disease associated with ovarian stimulation and assisted conception techniques. Human Reproduction 1997; 12: 2167–2173